|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/496 | (2006.01) |
| A61P 35/00 | (2018.01) | ||
| A61K 31/55 | (2006.01) | ||
| A61K 31/55 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61P 35/02 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61P 35/04 | (2006.01) | ||
| A61K 31/496 | (2013.01) | ||
| A61P 35/04 | (2018.01) |
| (11) | Patento numeris | 3843751 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 20847777.8 |
| Europos patento paraiškos padavimo data | 2020-07-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-07-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-03-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2020/105810 |
| Data | 2020-07-30 |
| (87) | Numeris | WO 2021/018240 |
| Data | 2021-02-04 |
| (30) | Numeris | Data | Šalis |
| PCT/CN2019/098625 | 2019-07-31 | WO | |
| 202010631089 | 2020-07-03 | CN |
| (72) |
YANG, Dajun , CN
ZHAI, Yifan , CN
FANG, Douglas Dong , CN
TANG, Qiuqiong , CN
|
| (73) |
Ascentage Pharma (Suzhou) Co., Ltd. ,
Unit 701, Building B7, 218 Xinghu Street
Suzhou Industrial Park, Suzhou, Jiangsu 215000,
CN
Ascentage Pharma Group Corp Limited , 9/F, Wah Yuen Building 149 Queen's Road Central, Hong Kong, HK |
| (54) | COMBINATION PRODUCT OF A BCL-2/BCL-XL INHIBITOR AND A CHEMOTHERAPEUTIC AGENT AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF DISEASES |
| COMBINATION PRODUCT OF A BCL-2/BCL-XL INHIBITOR AND A CHEMOTHERAPEUTIC AGENT AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF DISEASES |